Mood disorders in childhood and adolescence

Revista Brasileira de Psiquiatria

Volumn 35, Issue SUPPL. 1, 2013, Pages

  Rocha, Thiago Botter Maio ^a   Zeni, Cristian Patrick ^a   Caetano, Sheila Cavalcante ^b   Kieling, Christian ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adolescent; Bipolar; Child; Depression; Mood

Indexed keywords

AMFEBUTAMONE; ARIPIPRAZOLE; CARBAMAZEPINE; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; LAMOTRIGINE; LITHIUM; LITHIUM CARBONATE; MIRTAZAPINE; NEFAZODONE; OLANZAPINE; OXCARBAZEPINE; PAROXETINE; PLACEBO; QUETIAPINE; RISPERIDONE; SERTRALINE; TOPIRAMATE; VALPROATE SEMISODIUM; VENLAFAXINE; ZIPRASIDONE;

ABDOMINAL PAIN; ACNE; AGITATION; AKATHISIA; ANOREXIA; ANXIETY; APPETITE DISORDER; ARTICLE; ASTHENIA; ATAXIA; BIPOLAR DISORDER; BLEEDING; BLOOD PRESSURE; BODY WEIGHT; BONE MARROW SUPPRESSION; CHILDHOOD DISEASE; COGNITIVE DEFECT; COGNITIVE THERAPY; CONSTIPATION; DEPRESSION; DIABETES INSIPIDUS; DIABETES MELLITUS; DIARRHEA; DIZZINESS; DROWSINESS; DYSLIPIDEMIA; GYNECOMASTIA; HAIR LOSS; HEADACHE; HUMAN; HYPERPROLACTINEMIA; HYPERTENSION; HYPONATREMIA; HYPOTENSION; INAPPROPRIATE VASOPRESSIN SECRETION; INSOMNIA; LIVER TOXICITY; META ANALYSIS (TOPIC); MOOD DISORDER; MYALGIA; NAUSEA; NERVOUSNESS; OVARY POLYCYSTIC DISEASE; PANCREATITIS; POLYDIPSIA; POLYURIA; PSYCHOMOTOR RETARDATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; SALIVATION; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SKIN BRUISING; SPINAL CORD DISEASE; STEVENS JOHNSON SYNDROME; SUICIDE; SWEATING; TACHYCARDIA; THROMBOCYTOPENIA; THYROID DISEASE; TINNITUS; TREMOR; URINE RETENTION; VIVID DREAM; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

ADOLESCENT; BIPOLAR DISORDER; CHILD; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; MOOD DISORDERS; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS;

EID: 84889659496     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/1516-4446-2013-S106     Document Type: Article

References (78)

1. Kim-Cohen J, Caspi A, Moffitt TE, Harrington H, Milne BJ, Poulton R. Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort. Arch Gen Psychiatry. 2003;60:709-17
2. Gore FM, Bloem PJ, Patton GC, Ferguson J, Joseph V, Coffey C, et al. Global burden of disease in young people aged 10-24 years: a systematic analysis. Lancet. 2011;377:2093-102
3. Thapar A, Collishaw S, Pine DS, Thapar AK. Depression in adolescence. Lancet. 2012;379:1056-67
4. Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorders in a community sample of older adolescents: prevalence, phenomenol-ogy, comorbidity, and course. J Am Acad Child Adolesc Psychiatry. 1995;34:454-63
5. Goldman S. Developmental epidemiology of depressive disorders. Child Adolesc Psychiatr Clin N Am. 2012;21:217-35
6. Costello EJ, Egger H, Angold A. 10-year research update review: the epidemiology of child and adolescent psychiatric disorders: I. methods and public health burden. J Am Acad Child Adolesc Psychiatry. 2005;44:972-86
7. Hankin BL, Abramson LY, Moffitt TE, Silva PA, McGee R, Angell KE. Development of depression from preadolescence to young adulthood: emerging gender differences in a 10-year longitudinal study. J Abnorm Psychol. 1998;107:128-40
8. Paus T, Keshavan M, Giedd JN. Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci. 2008;9:947-57
9. Weir JM, Zakama A, Rao U. Developmental risk I: depression and the developing brain. Child Adolesc Psychiatr Clin N Am. 2012;21:237-59
10. Weissman MM, Wickramaratne P, Nomura Y, Warner V, Verdeli H, Pilowsky DJ, et al. Families at high and low risk for depression: a 3- generation study. Arch Gen Psychiatry. 2005;62:29-36
11. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386-9
12. Costello EJ, Pine DS, Hammen C, March JS, Plotsky PM, Weissman MM, et al. Development and natural history of mood disorders. Biol Psychiatry. 2002;52:529-42
13. Birmaher B, Brent D; AACAP Work Group on Quality Issues, Bernet W, Bukstein O, Walter H, et al. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. 2007;46:1503-26
14. D'Angelo EJ, Augenstein TM. Developmentally informed evaluation of depression: evidence-based instruments. Child Adolesc Psychiatr Clin N Am. 2012;21:279-98
15. Horowitz LM, Bridge JA, Teach SJ, Ballard E, Klima J, Rosenstein DL, et al. Ask Suicide-Screening Questions (ASQ): a brief instrument for the pediatric emergency department. Arch Pediatr Adolesc Med. 2012;166:1170-6
16. Brown HE, Pearson N, Braithwaite RE, Brown WJ, Biddle SJ. Physical activity interventions and depression in children and adolescents: a systematic review and meta-analysis. Sports Med. 2013;43:195-206
17. Maalouf FT, Brent DA. Child and adolescent depression intervention overview: what works, for whom and how well? Child Adolesc Psychiatr Clin N Am. 2012;21:299-312
18. Weisz JR, McCarty CA, Valeri SM. Effects of psychotherapy for depression in children and adolescents: a meta-analysis. Psychol Bull. 2006;132:132-49
19. Klein JB, Jacobs RH, Reinecke MA. Cognitive-behavioral therapy for adolescent depression: a meta-analytic investigation of changes in effect-size estimates. J Am Acad Child Adolesc Psychiatry. 2007;46:1403-13
20. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004;292:807-20
21. Brent D, Emslie G, Clarke G, Wagner KD, Asarnow JR, Keller M, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. 2008:299;901-13
22. Kennard BD, Emslie GJ, Mayes TL, Nightingale-Teresi J, Nakonezny PA, Hughes JL, et al. Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder. J Am Acad Child Adolesc Psychiatry. 2008;47:1395-404
23. Mufson L, Dorta KP, Wickramaratne P, Nomura Y, Olfson M, Weissman MM. A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry. 2004;61:577-84
24. Tompson MC, Boger KD, Asarnow JR. Enhancing the developmental appropriateness of treatment for depression in youth: integrating the family in treatment. Child Adolesc Psychiatr Clin N Am. 2012;21:345-84
25. Goodyer IM, Tsancheva S, Byford S, Dubicka B, Hill J, Kelvin R, et al. mproving mood with psychoanalytic and cognitive therapies (IMPACT): a pragmatic effectiveness superiority trial to investigate whether specialised psychological treatment reduces the risk for relapse in adolescents with moderate to severe unipolar depression: study protocol for a randomised controlled trial. Trials. 2011;12:175
26. Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a metaanalysis of randomized controlled trials. JAMA. 2007;297:1683-96
27. Pfeffer CR. The FDA pediatric advisories and changes in diagnosis and treatment of pediatric depression. Am J Psychiatry. 2007;164:843-6
28. Goodyer I, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, et al. Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial. BMJ. 2007;335:142
29. Cox GR, Callahan P, Churchill R, Hunot V, Merry SN, Parker AG, et al. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents. Cochrane Database Syst Rev. 2012;11:CD008324
30. Hetrick SE, McKenzie JE, Cox GR, Simmons MB, Merry SN. Newer generation antidepressants for depressive disorders in children and adolescents. Cochrane Database Syst Rev. 2012;11:CD004851
31. Cox GR, Fisher CA, De Silva S, Phelan M, Akinwale OP, Simmons MB, et al. Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents. Cochrane Database Syst Rev. 2012;11:CD007504
32. Weissman MM, Pilowsky DJ, Wickramaratne PJ, Talati A, Wisniewski SR, Fava M, et al. Remissions in maternal depression and child psychopathology: a STAR*D-child report. JAMA. 2006;295:1389-98
33. Stallard P, Sayal K, Phillips R, Taylor JA, Spears M, Anderson R, et al. Classroom based cognitive behavioural therapy in reducing symptoms of depression in high risk adolescents: pragmatic cluster randomised controlled trial. BMJ. 2012;345:e6058
34. Perlis RH, Smoller JW, Fava M, Rosenbaum JF, Nierenberg AA, Sachs GS. The prevalence and clinical correlates of anger attacks during depressive episodes in bipolar disorder. J Affect Disord. 2004;79:291-5
35. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM. The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord. 1994;31:281-94
36. Costello EJ, Angold A, Burns BJ, Erkanli A, Stangl DK, Tweed DL. The Great Smoky Mountains Study of Youth. Functional impairment and serious emotional disturbance. Arch Gen Psychiatry. 1996;53:1137-43
37. Fleitlich-Bilyk B, Goodman R. Prevalence of child and adolescent psychiatric disorders in southeast Brazil. J Am Acad Child Adolesc Psychiatry. 2004;43:727-34
38. Merikangas KR, Cui L, Kattan G, Carlson GA, Youngstrom EA, Angst J. Mania with and without depression in a community sample of US adolescents. Arch Gen Psychiatry. 2012;69:943-51
39. Soutullo CA, Chang KD, Diéz-Suárez A, Figueroa-Quintana A, Escamilla-Canales I, Rapado-Castro M, et al. Bipolar disorder in children and adolescents: international perspective on epidemiology and phenomenology. Bipolar Disord. 2005;7:497-506
40. Tramontina S, Schmitz M, Polanczyk G, Rohde LA. Juvenile bipolar disorder in Brazil: clinical and treatment findings. Biol Psychiatry. 2003;53:1043-9
41. Geller B, Luby J. Child and adolescent bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 1997;36:1168-76
42. Chang K, Steiner H, Ketter T. Studies of offspring of parents with bipolar disorder. Am J Med Genet C Semin Med Genet. 2003;123C:26-35
43. Birmaher B, Axelson D, Monk K, Kalas C, Goldstein B, Hickey MB, et al. Lifetime psychiatric disorders in school-aged offspring of parents with bipolar disorder: the Pittsburgh Bipolar Offspring study. Arch Gen Psychiatry. 2009;66:287-96
44. Petresco S, Gutt EK, Krelling R, Lotufo Neto F, Rohde LA, Moreno RA. The prevalence of psychopathology in offspring of bipolar women from a Brazilian tertiary center. Rev Bras Psiquiatr. 2009;31:240-6
45. Geller B, Tillman R, Bolhofner K, Zimerman B. Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome. Arch Gen Psychiatry. 2008;65:1125-33
46. Birmaher B, Axelson D, Strober M, Gill MK, Valeri S, Chiappetta L, et al. Clinical course of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry. 2006;63:175-83
47. DelBello MP, Hanseman D, Adler CM, Fleck DE, Strakowski SM. Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. Am J Psychiatry. 2007;164:582-90
48. Birmaher B, Axelson D, Goldstein B, Strober M, Gill MK, Hunt J, et al. Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study. Am J Psychiatry. 2009;166:795-804
49. Biederman J, Mick E, Faraone SV, Spencer T, Wilens TE, Wozniak J. Current concepts in the validity, diagnosis and treatment of paediatric bipolar disorder. Int J Neuropsychopharmacol. 2003;6:293-300
50. Sala R, Axelson D, Birmaher B. Phenomenology, longitudinal course, and outcome of children and adolescents with bipolar spectrum disorders. Child Adolesc Psychiatr Clin N Am. 2009;18:273-89
51. Pavuluri MN, Birmaher B, Naylor MW. Pediatric bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 2005;44:846-71
52. Axelson D, Birmaher B, Strober M, Gill MK, Valeri S, Chiappetta L, et al. Phenomenology of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry. 2006;63:1139-48
53. Birmhaer B, Axelson D, Pavuluri M. Bipolar disorder. In: Martin A, Volkmar FR, editors. Lewis's child and adolescent psychiatry: a comprehensive textbook. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 513-28
54. Birmaher B. Longitudinal course of pediatric bipolar disorder. Am J Psychiatry. 2007;164:537-9
55. Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorder during adolescence and young adulthood in a community sample. Bipolar Disord. 2000;281-93
56. Goldstein BI, Strober MA, Birmaher B, Axelson DA, Esposito- Smythers C, Goldstein TR, et al. Substance use disorders among adolescents with bipolar spectrum disorders. Bipolar Disord. 2008;10:469-78
57. American Psychiatric Association. Diagnostic and statistical manual of mental disorders - DSM-IV-TRH. 4th ed. Arlington: American Psychiatric Publishing; 1994
58. Leibenluft E, Charney DS, Towbin KE, Bhangoo RK, Pine DS. Defining clinical phenotypes of juvenile mania. Am J Psychiatry. 2003;160:430-7
59. Geller B, Bolhofner K, Craney JL, Williams M, DelBello MP, Gundersen K. Psychosocial functioning in a prepubertal and early adolescent bipolar disorder phenotype. J Am Acad Child Adolesc Psychiatry. 2000;39:1543-8
60. Zeni CP, Tramontina S, Ketzer CR, Pheula GF, Rohde LA. Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial. J Child Adolesc Psychopharmacol. 2009;19:553-61
61. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36: 980-8
62. Achenbach TM, Dumenci L. Advances in empirically based assessment: revised cross-informant syndromes and new DSM-oriented scales for the CBCL, YSR, and TRF: comment on Lengua, Sadowksi, Friedrich, and Fischer (2001). J Consult Clin Psychol. 2001;69:699-702
63. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429-35
64. Brasil HH, Bordin IA. Convergent validity of K-SADS-PL by comparison with CBCL in a Portuguese speaking outpatient population. BMC Psychiatry. 2003;10:83
65. Vilela JA, Crippa JA, Del-Ben CM, Loureiro SR. Reliability and validity of a Portuguese version of the Young Mania Rating Scale. Braz J Med Biol Res. 2005;38:1429-39
66. Bordin IAS, Mari JJ, Caeiro MF. [Validation of the Brazilian version of the Child Behavior Checklist (CBCL)]. Rev ABPAPAL. 1995;17: 55-66
67. McClellan J, Kowatch R, Findling RL, Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2007;46:107-25
68. Peruzzolo TL, Tramontina S, Rohde LA, Zeni CP. Pharmacotherapy for bipolar disorder in children and adolescents: an update. Rev Bras Psiquiatr. In press
69. Vitiello B, Riddle MA, Yenokyan G, Axelson DA, Wagner KD, Joshi P, et al. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. J Am Acad Child Adolesc Psychiatry. 2012;51:867-78
70. Liu HY, Potter MP, Woodworth KY, Yorks DM, Petty CR, Wozniak JR, et al. Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2011;50:749-62
71. Nandagopal JJ, DelBello MP, Kowatch R. Pharmacologic treatment of pediatric bipolar disorder. Child Adolesc Psychiatr Clin N Am. 2009;18:455-69
72. Kowatch RA, Fristad M, Birmaher B, Wagner KD, Findling RL, Hellander M, et al. Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2005;44:213-35
73. Miklowitz DJ. Family treatment for bipolar disorder and substance abuse in late adolescence. J Clin Psychol. 2012;68:502-13
74. Miklowitz DJ, Simoneau TL, George EL, Richards JA, Kalbag A, Sachs-Ericsson N, et al. Family-focused treatment of bipolar disorder: 1-year effects of a psychoeducational program in conjunction with pharmacotherapy. Biol Psychiatry. 2000;48:582-92
75. Pavuluri MN, Graczyk PA, Henry DB, Carbray JA, Heidenreich J, Miklowitz DJ. Child- and family-focused cognitive-behavioral therapy for pediatric bipolar disorder: development and preliminary results. J Am Acad Child Adolesc Psychiatry. 2004;43:528-37
76. Miklowitz DJ, George EL, Axelson DA, Kim EY, Birmaher B, Schneck C, et al. Family-focused treatment for adolescents with bipolar disorder. J Affect Disord. 2004;82:S113-28
77. Feeny NC, Danielson CK, Schwartz L, Youngstrom EA, Findling RL. Cognitive-behavioral therapy for bipolar disorders in adolescents: a pilot study. Bipolar Disord. 2006;8:508-15
78. Goldstein TR, Goldstein BI, Mantz MB, Bailey B, Douaihy A. A brief motivational intervention for preventing medication-associated weight gain among youth with bipolar disorder: treatment development and case report. J Child Adolesc Psychopharmacol. 2012;21:275-80.